0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ÏÁõ»ó°ú ÇǷΰ¡ ¼ÒÈ­±â ¾Ï ȯÀÚÀÇ Ç×¾ÏÈ­Çпä¹ý °ü·Ã ÀÎÁö±â´É °¨Åð¿Í ¿ì¿ï¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer

Journal of Korean Academy of Nursing 2016³â 46±Ç 3È£ p.420 ~ 430
KMID : 0806120160460030420
¿Àº¹ÀÚ ( Oh Pok-Ja ) - »ïÀ°´ëÇб³ °£È£Çаú

ÀÌÁ¤¶õ ( Lee Jung-Ran ) - »ïÀ°´ëÇб³ °£È£Çаú

Abstract

Purpose: The purpose of this study was to test a hypothetical model of chemotherapy-related cognitive impairment (CRCI) and depressionin people with gastrointestinal cancer.

Methods: A purposive sample of 198 patients undergoing chemotherapy was recruited from November2014 to July 2015. The instruments were Everyday Cognition (ECog), Hospital Anxiety Depression Scale (HADS), Functional Assessmentof Chronic Illness Therapy-Fatigue (FACIT-F), and M. D. Anderson Symptom Inventory-Gastrointestinal Cancer Module. Data were analyzedusing descriptive statistics, correlation, and path analysis.

Results: CRCI was directly affected by cancer symptoms (©¬=.19, p =.004) and fatigue(©¬=.56, p <.001)(R 2=47.2%). Depression was directly affected by fatigue (©¬=.48, p <.001) and CRCI (©¬=.27, p <.001). However, The impactof cancer symptoms on depression was confirmed through the mediating effect of CRCI.

Conclusion: Results indicate that in patientswith gastrointestinal cancer undergoing chemotherapy along with the direct physiologic effects (fatigue, symptoms) of cancer treatmentmay have altered cognitive function leading to depression.
KeyWords
°æµµÀÎÁö¼Õ»ó, ¾Ï, ÇÇ·Î, ¿ì¿ï
Mild cognitive impairment, Neoplasm, Fatigue, Depression
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed